Erasca, Inc.

ERAS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q May 13, 2025 10-Q
8-K May 13, 2025 8-K
ARS Apr 29, 2025 ARS
DEFA14A Apr 29, 2025 DEFA14A
DEF 14A Apr 29, 2025 DEF 14A
144 Apr 15, 2025
10-K Mar 20, 2025 10-K
8-K Mar 20, 2025 8-K
144 Mar 17, 2025
144 Feb 18, 2025
4 Feb 18, 2025 4
SCHEDULE 13G/A Feb 13, 2025
SCHEDULE 13G/A Feb 12, 2025
4 Feb 5, 2025 4
4 Feb 5, 2025 4
4 Feb 5, 2025 4
4 Feb 5, 2025 4
144 Jan 15, 2025
8-K Jan 13, 2025 8-K
4 Jan 2, 2025 4
4 Jan 2, 2025 4
4 Jan 2, 2025 4
4 Jan 2, 2025 4
144 Dec 16, 2024
144 Nov 15, 2024
← Newer Page 5 of 14 · 350 filings Older →